Published in Med Sci Monit on June 01, 2011
Predictors of cardiac hepatopathy in patients with right heart failure. Med Sci Monit (2011) 0.81
Hepatosplanchnic circulation in cirrhosis and sepsis. World J Gastroenterol (2015) 0.78
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (1999) 3.38
Clinical practice. Diastolic heart failure. N Engl J Med (2004) 2.79
Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation (2003) 1.96
Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol (2008) 1.86
Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. Am J Cardiol (2001) 1.79
Cardiac abnormalities in liver cirrhosis. West J Med (1989) 1.66
Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Clin Sci (Lond) (2001) 1.08
Heart rate turbulence: a 5-year review. Heart Rhythm (2004) 1.03
Cardiac dysfunction in cirrhosis. Best Pract Res Clin Gastroenterol (2007) 1.02
Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol (1984) 0.98
Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol (2002) 0.95
Cirrhotic cardiomyopathy. Gastroenterol Clin Biol (2002) 0.95
Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol (2005) 0.95
Cardiac evaluation of liver transplant candidates. World J Gastroenterol (2008) 0.93
B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis. Liver Int (2010) 0.89
Cirrhotic cardiomyopathy. Ann Hepatol (2006) 0.88
Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease. Eur J Gastroenterol Hepatol (2008) 0.86
Heart rate turbulence and clinical prognosis in hypertrophic cardiomyopathy and myocardial infarction. Circ J (2003) 0.82
Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit (2011) 0.81
Clinical significance of heart rate turbulence assessment in patients with chronic heart failure. Kardiol Pol (2008) 0.80
Characteristics of heart beat intervals and prediction of death. Int J Cardiol (2005) 0.80
Cardiac hemodynamic profiles and pro-B-type natriuretic Peptide in cirrhotic patients undergoing liver transplantation. Transplant Proc (2009) 0.78
Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease. Pol Arch Med Wewn (2011) 1.40
Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res (2010) 1.14
Short-term supplementation with Aronia melanocarpa extract improves platelet aggregation, clotting, and fibrinolysis in patients with metabolic syndrome. Eur J Nutr (2011) 0.92
Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia. Int J Biochem Cell Biol (2004) 0.92
Distribution of HCV genotypes in Poland. Przegl Epidemiol (2013) 0.91
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Expert Opin Drug Saf (2015) 0.89
Echocardiographic indices of left ventricular hypertrophy and diastolic function in hypertensive patients with preserved LVEF classified as dippers and non-dippers. Arch Med Sci (2013) 0.88
Effect of polyphenols extracts from Brassica vegetables on erythrocyte membranes (in vitro study). Environ Toxicol Pharmacol (2012) 0.85
Effect of statins on platelet function in patients with hyperlipidemia. Arch Med Sci (2013) 0.84
Disorders of erythrocyte structure and function in hypertensive patients. Med Sci Monit (2012) 0.83
Influence of statins on effector and regulatory immune mechanisms and their potential clinical relevance in treating autoimmune disorders. Med Sci Monit (2010) 0.83
Comprehensive insight into immune regulatory mechanisms and vascular wall determinants of atherogenesis - emerging perspectives of immunomodulation. Arch Med Sci (2013) 0.81
[Is healthcare personnel the only professional group exposed tothe risk of occupational HBV, HCV or HIV infections?]. Med Pr (2010) 0.81
Increased oxidative stress and decreased membrane fluidity in erythrocytes of CAD patients. Biochem Cell Biol (2013) 0.80
Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia. Can J Physiol Pharmacol (2003) 0.80
Herpes simplex encephalitis: a case report. Med Sci Monit (2004) 0.79
Hypolipidemic and antioxidant effects of hydroxycinnamic acids, quercetin, and cyanidin 3-glucoside in hypercholesterolemic erythrocytes (in vitro study). Eur J Nutr (2011) 0.78
Effect of short‑term testosterone replacement therapy on heart rate variability in men with hypoandrogen‑metabolic syndrome. Pol Arch Med Wewn (2013) 0.78
A competitor DNA template for the molecular quantification of the hepatitis B virus. Cell Mol Biol Lett (2003) 0.77
Extract of Aronia melanocarpa-modified hemostasis: in vitro studies. Eur J Nutr (2014) 0.77
[Hormonal activity of the hypophysial-gonadal axis versus the mineral bone density and specific markers of bone turnover in haemodialysis population]. Pol Merkur Lekarski (2006) 0.76
Recurrent syncope and hypocalcaemic cardiomyopathy as manifestations of Fahr's syndrome. Arch Med Sci (2010) 0.76
Persistent ductus arteriosus in a 72-year-old woman with paroxysmal atrial fibrillation and depression syndrome: a therapeutic and diagnostic problem. Arch Med Sci (2011) 0.75
The effect of 7-ketocholesterol and 25-hydroxycholesterol on the integrity of the human aortic endothelial and intestinal epithelial barriers. Inflamm Res (2013) 0.75
Hepatitis and the polyglandular autoimmune syndrome, type 1. Arch Med Sci (2011) 0.75
In vivo influence of extract from Aronia melanocarpa on the erythrocyte membranes in patients with hypercholesterolemia. Med Sci Monit (2012) 0.75
[HBV genotypes among patients with chronic hepatitis B in the area of central Poland]. Przegl Epidemiol (2006) 0.75
[The role of dronedarone in the contemporary atrial fibrillation treatment]. Pol Merkur Lekarski (2011) 0.75
Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students. Med Sci Monit (2002) 0.75
[Evaluation of effects of cardiac rehabilitation in patients after coronary artery bypass grafting by six minute walk test]. Pol Merkur Lekarski (2014) 0.75
[Statins in chronic heart failure--new indication?]. Pol Merkur Lekarski (2006) 0.75
[Cognitive disturbances observed in chronic hepatitis C patients during pegylated interferon alpha and ribavirin therapy]. Psychiatr Pol (2009) 0.75
[Increased level of lipid peroxidation products and disturbances in oxidation-reduction balance in erythrocytes from patients suffering from systemic sclerosis, who are chronically treated with vitamin E]. Pol Merkur Lekarski (2013) 0.75
[The evaluation of selected oxidative stress parameters in patients after radioiodine treatment of hyperthyroidism]. Pol Merkur Lekarski (2012) 0.75
[Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances]. Pol Merkur Lekarski (2014) 0.75
Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment. Pol Arch Med Wewn (2016) 0.75
[Peginterferon alpha-2b in patients with chronic hepatitis C]. Pol Merkur Lekarski (2004) 0.75
[Depressive disorders and symptoms accompanying pegylated interferon alpha and ribavirin treatment of chronic hepatitis C patients]. Pol Merkur Lekarski (2008) 0.75
[The effect of 7-ketocholesterol on surface ICAM-1 and PECAM-1 expression in human aortic endothelial cells]. Pol Merkur Lekarski (2014) 0.75
[The relationship between testosterone deficiency and metabolic syndrome in obese men]. Pol Merkur Lekarski (2013) 0.75
[Heart rate recovery after exercise in subjects undergoing cardiologic rehabilitation]. Pol Merkur Lekarski (2012) 0.75
[Evaluation of thrombin generation and clot bound thrombin in plasma of hyperlipidemic patients treated with statins]. Przegl Lek (2005) 0.75
[Attention abnormalities in patients with chronic hepatitis C after pegylated interferon alpha and ribavirin treatment]. Pol Merkur Lekarski (2008) 0.75
[Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis]. Pol Merkur Lekarski (2004) 0.75
[Rimonabant--a panacea for patients with metabolic syndrome?]. Pol Arch Med Wewn (2006) 0.75
[Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation]. Pol Merkur Lekarski (2014) 0.75
[Oxidative-reductive balance in patients after acute coronary syndrome that undergo cardiac rehabilitation]. Pol Merkur Lekarski (2014) 0.75
[Evaluation of bone mineral density in women with chronic liver diseases during perimenopausal period]. Pol Arch Med Wewn (2006) 0.75